Navigation Links
Redbiotec and TeselaGen to Partner on Herpesvirus Vaccine Library
Date:8/30/2013

Zurich, Switzerland and San Francisco, CA, August 30, 2013 (PRWEB) August 30, 2013

Redbiotec will contribute its proprietary rePAX® technology for production of virus-like particles (VLPs) and multi-protein complexes and their expertise in the field of HCMV (human cytomegalovirus) to build a verified library of VLPs/multi-protein complexes for vaccine development and testing. By using TeselaGen’s technology, Redbiotec expects to accelerate the development of the new library. This library also will help reveal potential causes of virus latency and help elucidate virus-triggered cancer mechanisms.

TeselaGen will contribute its proprietary Synthetic Evolution® technology, which uses synthetic biology approaches to build and modify DNA and automate library creation as well as statistical learning approaches to model performance of VLPs/multi-protein complexes and feed information back into the design process. The two companies will work together to enhance their respective technologies to meet the joint venture’s objectives.

“Redbiotec’s deep experience in VLP production and synthetic virology is very valuable to TeselaGen as we develop our technology to solve real world problems. We are very impressed with Redbiotec’s work on HCMV and are eager to help speed the development pipeline to go after vaccine candidates for Herpes,” said Michael Fero, CEO, TeselaGen. “Our partnerships with key industrial sectors in biotechnology are allowing us to build technology that adds a great deal of real-world value. We are convinced our synthetic biology approaches are going to prove very successful.”

“TeselaGen’s experience and capabilities in automated DNA design are very important to Redbiotec”, said Christian Schaub, CEO, Redbiotec. “Our concept for novel Herpesvirus vaccines candidates requires the collection of a large amount of data on DNA as well as on manufacturing and analysis of the expressed viral constructs. In 2012 we surveyed the market for potential partners and discovered an ideal strategic partner in TeselaGen. TeselaGen is at the leading edge in terms of creating bio design technology that talks directly to high-throughput bio-production. After our achievements with HCMV vaccine development we are excited to apply both partners’ skills and technology to extend our pipeline further into Herpesviruses.”

Read the full story at http://www.prweb.com/releases/2013/8/prweb11069569.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genomatica Licenses TeselaGen Software for DNA Design
2. Sales Momentum and Blue Pacific Sales Training Partner in Exciting New E-Learning Sales Training
3. Golden West Biologicals Names Matriks as Distribution Partner in Norway
4. ANP to present at and attend major US investment, partnering and industry conferences
5. EnduRx Pharmaceuticals to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
6. Convoy Therapeutics to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
7. Sales Momentum and Covocative Partner to Improve Sales Coaching Effectiveness
8. Golden West Biologicals Names New Korean Distribution Partner
9. Ironridge Global Partners, LLC Successfully Concludes Equity Financings of ULURU Inc.
10. Former Head of UK Medicines & Healthcare Products Regulatory Agency (MHRA) Sir Alasdair Breckenridge Joins NDA Partners
11. Study Scavenger and CenterWatch Partner to Improve Patient Recruitment, Enrollment and Mobile Access to Clinical Trials with New Study Scavenger Smartphone App
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... June 23, 2016  Blueprint Bio, a company dedicated ... the medical community, has closed its Series A funding ... . "We have received a commitment from ... we need to meet our current goals," stated ... the runway to complete validation on the current projects ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
Breaking Biology Technology:
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
(Date:3/21/2016)... 2016 Unique technology combines ... superior security   Xura, Inc. ... secure digital communications services, today announced it is working ... enterprise customers, particularly those in the Financial Services Sector, ... authentication within a mobile app, alongside, and in combination ...
Breaking Biology News(10 mins):